AI @ Pfizer

Pfizer continues systematic AI/ML embedding across R&D, commercial, manufacturing, and regulatory functions, reinforcing industry leadership in AI-driven pharma innovation and operational efficiency.

• Klover AI: Pfizer's AI Strategy: Analysis of Dominance in Pharma

Expansion of AI-driven small molecule discovery collaboration with XtalPi using the XFEP platform; highlighting Pfizer's shortening of drug discovery timeframes from years to roughly 30 days; AI improves patient program scalability and experience.

• Fierce Biotech: Pfizer expands XtalPi small-molecule discovery collaboration
• Chief AI Officer: How Pfizer Cut Drug Discovery Time From Years to 30 Days and What Every CEO Can Learn

Introduction of generative AI-powered consumer digital product answering health questions; expansion of AI partnership with PostEra for medicinal chemistry accelerating discovery with 40% faster preclinical milestones and $350M investment in AI-driven R&D.

• Pfizer: A New Consumer Digital Product Providing Answers You Can Trust
• C&EN: Pfizer doubles down on AI partnership with antibody-drug conjugate startup

Pfizer's AI-driven drug discovery demonstrated by reducing clinical trial failure rates and time to market, notably for COVID vaccines and antivirals; partnerships with Tempus and internal ML Research Hub enhance pipeline insights.

• Virtasant: Pfizer's AI Drug Discovery Cuts Years Off Development Time

Appointment of Berta Rodriguez-Hervas as Chief AI and Analytics Officer to strengthen global AI strategy; AI identified as essential for accelerating drug market entry.

• Technology Magazine: New AI Chief at Pfizer to Boost Digital Innovation

Collaborations with CeMM focus on AI-driven drug discovery methods measuring molecule-protein interactions; recognition by physicians of Pfizer's AI leadership in drug discovery; initiatives in AI-powered compliance copilots.

• Fierce Biotech: Pfizer collab with CeMM leads to new drug discovery AI models

Launch of 'Charlie,' a generative AI content platform boosting Pfizer's marketing content creation and approval efficiencies up to 5x; adoption of AI in clinical trial data oversight; enhanced AI personalization in marketing.

• Digiday: With 'Charlie,' Pfizer is building a new generative AI platform for pharma marketing
• PharmiWeb: How Pfizer is Revolutionising Pharma Marketing with AI

Introduction of generative AI in business narrative with 17 use cases; Pfizer publishes AI policy emphasizing ethical governance in AI use.

• CIO.inc: How Gen AI Is Helping Pfizer Change Healthcare Narrative
• Pfizer: Policy Position on Artificial Intelligence

Pfizer intensifies AI/ML deployment aiming to expedite transformative medicines reaching patients faster through collaborative scaling efforts.

• BioSpace: Pfizer Doubles Down on AI/ML to Bring Transformative Medicines to Patients

Detailed analysis of three AI use cases at Pfizer highlighted how AI supports immediate business objectives in pharmaceutical development.

• Emerj Artificial Intelligence Research: Artificial Intelligence at Pfizer - 3 Use Cases

Pfizer publicly stresses AI's role in accelerating vaccine and medicine development combining supercomputing and AI techniques.

• Pfizer Insights: Pfizer Is Using AI to Discover Breakthrough Medicines

Early AI activities highlighted, including collaboration with IBM Watson to explore machine learning and natural language processing for drug discovery.

• BioPharma Dive: Pharma and AI? Let's try augmented intelligence first